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Abstract:  Cryptogenic  stroke  and  transient  ischemic  attack  (TIA)  account  for  approximately  one-third  of  stroke  patients  [1].
Paroxys-mal atrial fibrillation (PAF) has been suggested as a major etiology of these cryptogenic strokes [2, 3]. PAF can be difficult
to diagnose because it is intermittent, often brief, and asymptomatic. PAF might be more prevalent than persistent atrial fibrillation in
stroke  and  TIA  patients,  especially  in  younger  populations  [4,  5].  In  patients  with  atrial  fibrillation,  anticoagulation  provides
significant  risk  reduction  [6].  A  new  generation  of  oral  anticoagulants  has  been  approved  for  non-valvular  atrial  fibrillation,
providing a variety of therapeutic options for patients with atrial fibrillation and risk of stroke [7].
Prior practice included an admission electrocardiogram (ECG) and continuous telemetry monitoring while in hospital [8]. However,
this approach can lead to under-detection of brief asymptomatic events, which can occur at variable intervals, often outside of the
hospital setting. Technological advancements have led to devices that can monitor cardiac rhythms outside of the hospital for longer
durations resulting in higher yield of detection of atrial fibrillation events.
Moreover, recent studies show that the normal monitoring time for arrhythmias may be shorter than ideal in order to detect atrial
fibrillation, and increasing this interval could significantly improve detection of atrial fibrillation in these patients [9, 10].
The aim of this study is to review the literature in order to define what subgroup of patients, with what methodologies, and for how
long monitoring for atrial fibrillation should occur in patients presenting with cryptogenic stroke.
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PATIENT SELECTION
In order for long-term monitoring to have a reasonable yield, factors that can more reliably predict PAF should be
considered. Several studies have identified multiple predictors of PAF including advanced age, female gender, diabetes,
hypertension,  sleep  apnea,  premature  atrial  complexes  (PACs)  on  ECG,  abnormal  p-wave  morphology,  left  atrial
dilatation, reduced left ventricular ejection fraction (EF), congestive heart failure, valvular heart disease, coronary artery
disease,  higher  stroke  severity  on  the  National  Institute  of  Health  Stroke  Scale  (NIHSS),  non-lacunar  anterior
circulation  infarcts  on  neuroimaging,  and  cortical  infarcts  on  neuroimaging  [11  -  21].
It is important to note that all of these parameters are tested for under standard stroke unit protocols for patients with
cryptogenic  stroke.  The  demographics  and  history  are  obtained  at  initial  assessment.  Cardiac  parameters  can  be
obtained through  ECG and  transthoracic echocardiogram.  Neuroimaging parameters can  be obtained  through routine
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evaluation of these patients. Sleep studies, which are not routinely performed, can be added to the evaluation of patients
either in the hospital or during subsequent visits.
These predictors have been consolidated into scoring scales to provide a predictive model [16, 20, 22]. The STAF
prediction model includes variables such as age, NIHS score, left atrial dilatation and absence of cranial stenosis or
lacunar syndrome. The LADS scale includes left atrial diameter, age, diagnosis of stroke and smoking status. Although
STAF yields a high sensitivity and specificity, the variability of inter-rater reliability for NIHSS and TOAST may lower
the efficacy of this scale in different hospital settings [16, 20, 22]. The shortcomings of all these scales is that they have
relatively low accuracy.
In light of recent results showing that long-term monitoring was effective at detecting atrial fibrillation in patients
with  cryptogenic  stroke  [9,  10],  we  suggest  that  all  patients  with  previous  cryptogenic  stroke  based  on  hospital
evaluation should be monitored, regardless of their scores in the aforementioned scales.
DEVICE SELECTION
Routine ECG is  part  of  the initial  evaluation for patients  with stroke,  but  the yield for  PAF is  low. Continuous
cardiac telemetry while the patient is in the hospital for stroke improves this yield [23 - 25]. There are multiple devices
available for detecting PAF. Holter monitors are battery operated and record 2 to 3 different leads. These devices record
data that is then analyzed with the help of software to identify rhythm abnormalities. Patient-activated event markers
and time markers are also used to improve yield. Recorded tracings are then interpreted by cardiologists [26]. However,
a large number of patients with PAF will remain undetected when Holter is used because of a short monitoring duration.
Therefore, long term monitoring devices have been developed to address this issue [27]. These devices are worn
continuously and come in a variety of modalities. External loop or event recorders monitor the ECG into a memory
buffer loop that freezes upon patient activation, permitting capture of the ECG for several minutes before and after
activation. The monitor transmits these recordings by telephone by converting ECG data to audio signals. A central
receiving station reconstructs the electric signal into a conventional ECG recording for interpretation by cardiologists
[9, 26, 28].
The second option, mobile cardiac outpatient telemetry systems, can also provide detection of asymptomatic PAF,
whereas external loop recorders can only provide detection of symptomatic events. Patients wear a small transmitting
pendant that is connected to 3 ECG electrodes. The pendant transmits real-time ECG data to a cell phone-sized monitor
that analyzes the rhythm. These events are transmitted via the cellular network to a laboratory where technicians read
the episodes. Predetermined physician-set monitoring thresholds and response parameters are used to generate alerts.
Patients  can  also  activate  the  monitor  to  report  symptomatic  events  [4,  29].  Algorithms  have  been  developed  that
analyze R-R interval variability, QRS morphology, and P-wave presence to screen for PAF [30]. The settings generate
automatic alerts that facilitate detection of asymptomatic arrhythmias [26, 27, 29].
Finally, since the previous devices are surface recording devices that are potentially prone to artifacts, lead failure
and  patient  non-compliance.  Implantable  loop  recorders  are  helpful  in  this  regard.  These  devices  are  implanted
subcutaneously to overcome the aforementioned limitations. Current devices are capable of recording up to 50 minutes
of ECG. These data are then transmitted over the telephone or wirelessly for physician review. They can be implanted
for up to 3 years and can be explanted once a diagnosis is made or the battery life has ended [10, 26, 31].
The use of Holter monitoring has improved the detection of these events, but only provides recording capabilities
for  a  48-hour  period  [17,  24,  32,  33].  In  contrast,  long monitoring  devices  can  record  a  longer  period  (3-6  weeks)
improving the chance of diagnosing atrial fibrillation [23]. To our knowledge there is no study comparing sensitivity
and specificity for the different devices. Detection rates of atrial fibrillation range between 5-25% among the different
devices. These studies have different recording times, eligibility criteria and outcomes, hindering a useful comparison
between the different modalities [10, 27, 28, 31, 34].
Mobile  health  (mHealth)  applications  are  also  available  for  smartphones  that  allow  patients  to  check  for  AF
autonomously.  The  app  is  FDA-cleared  and  is  currently  available  for  patients  to  utilize  for  self-reporting  of
AF.  Preliminary  studies  indicate  high  use  rates  of  the  app  and  general  patient  satisfaction  and  improved  health
awareness [35], although it should be noted that this is a supplemental diagnostic tool that is still being evaluated. In
general, mHealth software and mobile applications have a great potential to involve patients in their own diagnosis and
treatment, and integrate physicians into the digitally connected platform of modern communications [36]. This could
result in decreased costs, increased efficiency and quality of medical care, and broader access to care, but must also be
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tempered by efforts to ensure patient privacy and minimize safety risks. Overall we believe it is a useful tool but serves
only as a supplement to the current standard monitoring devices.
DURATION
The appropriate duration of monitoring for arrhythmia is not well defined [27]. However, recent studies suggest that
longer duration is better [37]. The yield with surface event monitors ranges between 5%-25%, [10, 27] with an overall
detection rate of 11.5% [38]. The variability in detection rates is due to different monitoring durations. Moreover, the
criteria  for  events  to be diagnosed as atrial  fibrillation is  also variable,  with some studies using >30 seconds event
duration as a definite threshold for atrial fibrillation [27]. Recently published trials have highlighted the need for more
long-term monitoring [9, 10].
The Atrial  Fibrillation in Patients with Cryptogenic Stroke (EMBRACE) trial  randomized patients to long-term
monitoring (30 days of event monitoring) vs. conventional monitoring (24 hours of Holter monitoring). This trial found
a significant difference in atrial fibrillation detection (16.1% vs. 3.2%; P<0.001) [9].
The Cryptogenic Stroke and Underlying Atrial Fibrillation (CRYSTAL-AF) trial randomized patients to implanted
cardiac monitor (ICM) vs. conventional routine monitoring. This trial found a significant difference in atrial fibrillation
detection  both  at  6  months  (8.9% vs.  1.4%;  P<0.001)  and 12 months  (12.4% vs.  2.0%;  P<0.001)  [10].  At  3  years,
approximately 30% of implanted patients were found to have atrial fibrillation raising the question of whether the atrial
fibrillation detected after stroke is causal, a result, or an unrelated event.
It is important to note that both of these trials used a threshold of >30 seconds to define atrial fibrillation events.
These  trials  provide  much  needed  evidence  for  the  effectiveness  of  long-term  monitoring.  Importantly,  outpatient
monitoring after ischemic stroke can identify patients with PAF who will benefit from anticoagulation and it has shown
to be cost-effective after ischemic stroke [39]. We suggest 30-day event monitoring for all patients with cryptogenic
stroke. Further monitoring with ICM can be done in patients who have continued neurological events with previously
negative 30-day monitoring results.
CONCLUSION
Advancements  in  technology  have  led  to  improved  detection  of  atrial  fibrillation,  which  assists  physicians  in
management  of  patients  with previously defined cryptogenic stroke.  We recommend that  patients  with cryptogenic
stroke undergo long-term cardiac rhythm monitoring for at least 30 days. As recent studies have reported that detection
rates of atrial fibrillation increase with time, further research is needed to determine the ideal duration for monitoring
patients with cryptogenic stroke.
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